2006 ICD-9-CM Volume 1 Diagnosis Codes Home > Endocrine, Nutritional And Metabolic Diseases, And Immunity Disorders 240-279 > Other Metabolic Disorders And Immunity Disorders 270-279 > Disorders Of Lipoid Metabolism 272.* > 2006 ICD-9-CM Diagnosis 272.1 Pure hyperglyceridemia View the most recent version of ICD-9-CM 272.1 A familial disorder characterized by an isolated elevation in the plasma level of endogenously synthesized triglyceride carried in VLDL. It is considered to be an autosomal dominant trait. 272.1 is a specific code that can be used to specify a diagnosis 272.1 contains 17 index entries View the ICD-9-CM Volume 1 272.* hierarchy Alternate Terminology Endogenous hyperglyceridemia Fredrickson Type IV hyperlipoproteinemia Hyperlipidemia, Group B Hyperprebetalipoproteinemia Hypertriglyceridemia, essential Very-low-density-lipoid-type [VLDL] hyperlipoproteinemia  Index entries containing 272.1: Hyperglyceridemia 272.1 endogenous 272.1 essential 272.1 familial 272.1 hereditary 272.1 mixed 272.3 pure 272.1 Hyperlipidemia 272.4 carbohydrate-induced 272.1 endogenous 272.1 group B 272.1 Hyperlipoproteinemia (acquired) (essential) (familial) (hereditary) (primary) (secondary) 272.4 Fredrickson type IV 272.1 very-low-density-lipoid-type [VLDL] 272.1 Hyperprebetalipoproteinemia 272.1 with chylomicronemia 272.3 familial 272.1 Hypertriglyceridemia, essential 272.1 Lipoproteinemia (alpha) 272.4 hyper-pre-beta 272.1 Prebetalipoproteinemia (acquired) (essential) (familial) (hereditary) (primary) (secondary) 272.1 with chylomicronemia 272.3 Xanthoma(s), xanthomatosis 272.2 with hyperlipoproteinemia type IV 272.1